Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
giovedì, ottobre 22
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Ardelyx Inc
ARDX
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$3.13
-0.08
-2.49%
Ult. Agg.: Oct 22, 1:46 AM
$3.13
-0.08
-2.49%
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Privacy Manager
Utili:
I risultati di Q3 2026 tra 12 giorni da adesso in mar nov 3rd, dopo la chiusura del mercato
Ardelyx Financials
Ardelyx (ARDX) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Ardelyx Q2 EPS $(0.07) Misses $(0.05) Estimate, Sales $118.100M Miss $121.601M Estimate
Ardelyx (NASDAQ:ARDX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.05) by 40 percent. This is a 12.5 percent increase over losses of $(0.08) per share from the same
Benzinga Newsdesk
PRO
Ardelyx Q1 EPS $(0.15) Misses $(0.13) Estimate, Sales $94.473M Beat $92.655M Estimate
Ardelyx (NASDAQ:ARDX) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.13) by 15.38 percent. This is a 11.76 percent increase over losses of $(0.17) per share from the
Benzinga Newsdesk
Earnings Scheduled For April 30, 2026
Benzinga Insights
Ardelyx Lead Drug Growth Fails To Lift Sentiment, Stock Drops
Ardelyx stock drops premarket despite revenue beat as investors weigh IBSRELA growth outlook and mixed technical signals heading into 2026.
Vandana Singh
Ardelyx Q4 Earnings Report: What Investors Need to Know
Benzinga Insights
PRO
Ardelyx Q4 EPS $0.00 Misses $0.01 Estimate, Sales $125.215M Beat $118.134M Estimate
Ardelyx (NASDAQ:ARDX) reported quarterly earnings of $0.00 per share which missed the analyst consensus estimate of $0.01 by 85.71 percent. This is a 95 percent decrease over earnings of $0.02 per share from the same
Benzinga Newsdesk